|
시장보고서
상품코드
1983320
세포독성 약제 수탁제조 시장 : 생산 규모별, 제형별, 제품 유형별, 지역별Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, By Form, By Product Type, By Geography |
||||||
세포독성 약제 수탁제조 시장은 2026년에 126억 650만 달러로 추계되고 있으며, 2033년까지 231억 5,750만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 126억 650만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 9.10% | 2033년 시장 규모 예측 : | 231억 5,750만 달러 |
세포독성 의약품 수탁제조 시장은 지난 10년간 괄목할 만한 성장을 이루었습니다. 암 발병률 증가와 주요 기업의 사업 확장, 제휴, 인수 등 다양한 성장 전략의 채택 확대는 예측 기간 중 시장 성장을 가속할 것으로 예측됩니다. 제약회사 및 바이오테크 기업은 세포독성 의약품 및 고활성 원료의약품(HPAPI)의 연구개발에 종사하고 있으며, 자체적으로 의약품을 생산하거나 다른 제조업체에 생산을 위탁하고 있습니다.
시장 역학
암 발병률 증가는 예측 기간 중 시장 성장을 촉진할 것으로 예측됩니다. 예를 들어 미국암협회(American Cancer Society)의 추산에 따르면 2017년 미국에서 168만 8,780명이 암 진단을 받았고, 60만 920명이 암으로 사망한 것으로 보고되었습니다.
암 치료제의 승인 건수가 증가함에 따라 예측 기간 중 세계 세포독성 의약품 수탁제조 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어 2018년 10월 Catalent Pharma Solutions는 Verastem Oncology의 COPIKTRA(듀베리시브) 캡슐에 대해 미국 식품의약국(FDA)의 승인을 받았습니다.
또한 제약사들의 수탁제조 서비스 도입 확대는 예측 기간 중 세계 세포독성 의약품 수탁제조 시장의 성장을 촉진할 것으로 예측됩니다. 예를 들어 2018년 9월 GB Sciences, Inc.는 파킨슨병 치료제를 위해 자체 개발한 API(Active Pharmaceutical Ingredient)의 경구 투여 시스템, 제형 개발 및 임상 규모의 경구제 제조를 제공하는 파트너로 Catalent Pharma Solutions를 선정했습니다. 선정했습니다.
본 조사의 주요 특징
- 이 보고서는 세포독성 의약품 수탁제조 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 시장 규모와 CAGR%를 제시합니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 세포독성 의약품 수탁제조 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 재무 실적, 제품 포트폴리오, 시장에서의 존재감, 유통 전략, 주요 발전, 전략 및 향후 계획 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세포독성 의약품 수탁제조 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 세포독성 약제 수탁제조 시장 : 생산 규모별, 2026-2033년
제5장 세계의 세포독성 약제 수탁제조 시장 : 제형별, 2026-2033년
제6장 세계의 세포독성 약제 수탁제조 시장 : 제품 유형별, 2026-2033년
제7장 세계의 세포독성 약제 수탁제조 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.04.20Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at USD 12,606.5 Mn in 2026 and is expected to reach USD 23,157.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12,606.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.10% | 2033 Value Projection: | USD 23,157.5 Mn |
Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.
Market Dynamics
Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.
Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.
Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.
Key features of the study
- This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
- The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market
Market Segmentation
- Production Scale Insights (Revenue, USD Mn, 2026 - 2033)
- Industrial scale
- Pilot Scale
- Laboratory Scale
- Form Insights (Revenue, USD Mn, 2026 - 2033)
- Liquid
- Solid
- Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Oral
- Intravenous
- Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA (SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- BSP Pharmaceuticals S.p.A.
- CordenPharma Internatisonal
- Catalent, Inc.
- Albany Molecular Research Inc.
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Production Scale
- Market Snippet, By Form
- Market Snippet, By Product Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Product Launch
- Regulatory Scenario
- PEST Analysis
- Merger and Acquisition Scenario
- Technological Advancements
4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Industrial scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pilot Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Laboratory Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Liquid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Solid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Intravenous
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Lonza Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Piramal Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evonik Industries AG
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novasep Holding SAS
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA (SAFC Pharma)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter Biopharma Solutions
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Contract Manufacturing
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambrex Corporation
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CordenPharma International
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BSP Pharmaceuticals S.p.A.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Catalent, Inc.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Albany Molecular Research Inc. (AMRI)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evotec
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- WuXi AppTec Co., Ltd.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pierre Fabre Laboratories
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dishman Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Lonza Group
9. Section
- References
- Research Methodology
- About Us and Sales Contact
